tiprankstipranks
Trending News
More News >
Chemplast Sanmar Limited (IN:CHEMPLASTS)
:CHEMPLASTS
India Market
Advertisement

Chemplast Sanmar Limited (CHEMPLASTS) AI Stock Analysis

Compare
0 Followers

Top Page

IN:CHEMPLASTS

Chemplast Sanmar Limited

(CHEMPLASTS)

Rating:46Neutral
Price Target:
₹421.00
▼(-1.39% Downside)
Chemplast Sanmar Limited's overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues, shrinking margins, and high debt levels. The technical analysis indicates a bearish trend, further weighing on the score. The valuation is unattractive due to a negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.

Chemplast Sanmar Limited (CHEMPLASTS) vs. iShares MSCI India ETF (INDA)

Chemplast Sanmar Limited Business Overview & Revenue Model

Company DescriptionChemplast Sanmar Limited is a leading manufacturer in the chemical industry, primarily focused on the production of specialty chemicals and PVC resins. The company operates in various sectors including agriculture, automotive, construction, electronics, and healthcare, providing essential raw materials and intermediates for diverse applications. With a commitment to sustainability and innovation, Chemplast Sanmar Limited is known for its high-quality products and strong customer relationships.
How the Company Makes MoneyChemplast Sanmar Limited generates revenue through the sale of its specialty chemicals and PVC resins. The company's key revenue streams include domestic and international sales of these products, with a broad customer base spanning multiple industries. Strategic partnerships with suppliers and distributors enhance its market reach and contribute to its financial performance. Additionally, the company benefits from economies of scale and efficient manufacturing processes, which help maintain competitive pricing and profitability.

Chemplast Sanmar Limited Financial Statement Overview

Summary
Chemplast Sanmar Limited is facing significant financial challenges, with declining revenues, shrinking margins, and increasing debt levels. The company’s profitability has been severely impacted, resulting in net losses and negative free cash flow. These financial pressures are compounded by high leverage, which poses a risk to the company’s financial health.
Income Statement
45
Neutral
Chemplast Sanmar Limited has shown a volatile revenue trend with a decline in total revenue from 2022 to 2025. The gross profit margin has decreased over the years, and the company has faced significant net losses in recent years, particularly in 2024 and 2025. The EBIT margin turned negative in 2024, indicating operational challenges. The EBITDA margin also shrank, suggesting reduced operational efficiency.
Balance Sheet
55
Neutral
The company's balance sheet indicates a high debt-to-equity ratio due to increased total debt, which poses a risk to financial stability. The equity ratio demonstrates a moderate level of equity financing. However, the return on equity has been negative in recent years correlating with the net losses, which is a concern for investors.
Cash Flow
40
Negative
Chemplast Sanmar has struggled with negative free cash flow in recent years, indicating a cash burn issue. Operating cash flow to net income ratio has been unstable, reflecting inconsistent cash generation relative to earnings. The company's ability to generate free cash flow relative to net income is also poor, highlighting potential liquidity risks.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue43.46B43.46B39.16B49.41B58.85B37.93B
Gross Profit13.79B15.93B5.11B17.29B20.87B16.07B
EBITDA2.40B2.19B1.06B4.68B12.54B14.45B
Net Income-1.10B-1.10B-1.58B1.52B6.49B4.10B
Balance Sheet
Total Assets65.03B65.03B60.30B58.37B56.01B44.86B
Cash, Cash Equivalents and Short-Term Investments7.24B7.24B7.35B12.94B10.21B3.24B
Total Debt18.42B18.42B15.48B10.19B8.81B21.27B
Total Liabilities44.35B44.35B43.30B39.78B38.96B48.36B
Stockholders Equity20.68B20.68B17.01B18.58B17.05B-3.50B
Cash Flow
Free Cash Flow0.00-2.11B-8.64B-641.60M7.88B10.21B
Operating Cash Flow0.001.72B-2.45B3.55B9.01B10.76B
Investing Cash Flow0.00-4.07B-5.24B-2.17B1.08B21.52B
Financing Cash Flow0.00660.90M3.82B-269.90M-3.13B-30.17B

Chemplast Sanmar Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price426.95
Price Trends
50DMA
429.52
Negative
100DMA
427.54
Negative
200DMA
447.40
Negative
Market Momentum
MACD
-0.06
Positive
RSI
48.69
Neutral
STOCH
20.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMPLASTS, the sentiment is Negative. The current price of 426.95 is above the 20-day moving average (MA) of 424.93, below the 50-day MA of 429.52, and below the 200-day MA of 447.40, indicating a neutral trend. The MACD of -0.06 indicates Positive momentum. The RSI at 48.69 is Neutral, neither overbought nor oversold. The STOCH value of 20.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:CHEMPLASTS.

Chemplast Sanmar Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
₹53.00B8.56
2.17%-3.31%19.02%
70
Outperform
₹78.42B17.96
0.33%17.88%68.05%
68
Neutral
₹76.82B13.67
3.15%-9.97%9.63%
62
Neutral
₹80.93B51.39
0.61%-6.59%-41.72%
61
Neutral
$10.26B6.130.71%2.93%3.45%-36.02%
56
Neutral
₹50.29B20.63
0.49%7.46%33.79%
46
Neutral
₹67.50B
5.64%-181.28%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:CHEMPLASTS
Chemplast Sanmar Limited
426.95
-73.25
-14.64%
IN:ACI
Archean Chemical Industries Ltd.
669.25
-35.39
-5.02%
IN:EPIGRAL
Epigral Ltd
1,817.75
-22.81
-1.24%
IN:GHCL
Ghcl Limited
551.70
-105.80
-16.09%
IN:GNFC
Gujarat Narmada Valley Fertilizers & Chemicals Ltd.
537.70
-140.49
-20.72%
IN:INDIAGLYCO
India Glycols Limited
812.70
139.90
20.79%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 27, 2025